Radioligand therapy is now a board-level topic in Japan, not because the science is new, but […]
You fly in, you present, you charm the room. Heads nod. The technical team likes your […]
The surge I sensed at BioJapan 2025 in October reflects deliberate engineering rather than hype: targeted […]
A New Order is taking shape in Japan’s life sciences. Conference floors are packed, university benches […]